CD4 and neoplasm: NDMI score, but not DEX use at blood draw or neutrophil proportion, remained a significant predictor of survival time in a final model that included age, surgery, tumor location, WHO subtype, body mass index, CD4 T cell proportion, and an interaction between WHO subtype and NDMI score (Table 3).